Aytu Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Aytu BioScience
AYTU Stock  USD 2.72  0.02  0.74%   
Analyzing historical trends in various income statement and balance sheet accounts from Aytu BioScience's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Aytu BioScience's valuation are summarized below:
Gross Profit
43 M
Profit Margin
(0.21)
Market Capitalization
27.7 M
Enterprise Value Revenue
0.3463
Revenue
63.7 M
There are currently one hundred twenty fundamental signals for Aytu BioScience that can be evaluated and compared over time across rivals. All traders should validate Aytu BioScience's prevailing fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 23.8 M in 2026. Enterprise Value is likely to gain to about 22.2 M in 2026

Aytu BioScience Total Revenue

80.16 Million

Check Aytu BioScience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aytu BioScience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.5 M, Interest Expense of 4 M or Selling General Administrative of 12.3 M, as well as many indicators such as Price To Sales Ratio of 289, Dividend Yield of 0.0 or PTB Ratio of 3.5. Aytu financial statements analysis is a perfect complement when working with Aytu BioScience Valuation or Volatility modules.
  
Build AI portfolio with Aytu Stock
Check out the analysis of Aytu BioScience Correlation against competitors.
For more information on how to buy Aytu Stock please use our How to Invest in Aytu BioScience guide.

Aytu BioScience Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets149.9 M142.8 M79.7 M
Slightly volatile
Short and Long Term Debt Total27.7 M26.4 M14.9 M
Slightly volatile
Other Current Liabilities50 M47.6 M18.7 M
Slightly volatile
Total Current Liabilities76.1 M72.5 M33.9 M
Slightly volatile
Property Plant And Equipment Net1.4 M1.8 M1.6 M
Slightly volatile
Accounts Payable12.8 M12.2 M6.6 M
Slightly volatile
Cash37.4 M35.6 M17.7 M
Slightly volatile
Non Current Assets Total32.4 M51.7 M37.8 M
Slightly volatile
Cash And Short Term Investments37.4 M35.6 M17.8 M
Slightly volatile
Common Stock Shares Outstanding7.6 M7.2 M1.9 M
Slightly volatile
Liabilities And Stockholders Equity149.9 M142.8 M79.7 M
Slightly volatile
Non Current Liabilities Total50.9 M48.5 M18.6 M
Slightly volatile
Total Liabilities127 M121 M52.5 M
Slightly volatile
Property Plant And Equipment Gross1.6 M2.7 M1.9 M
Slightly volatile
Total Current Assets95.6 M91.1 M40.6 M
Slightly volatile
Short Term Debt13.4 M12.7 M5.7 M
Slightly volatile
Common Stock Total Equity2.6 K2.7 K63 K
Slightly volatile
Other Current Assets6.8 M6.5 M3.6 M
Slightly volatile
Common Stock85590062.5 K
Slightly volatile
Current Deferred Revenue27.6 M44.4 M18.4 M
Slightly volatile
Capital Surpluse259.6 M247.3 M130.1 M
Slightly volatile
Intangible Assets36.6 M48.5 M30.5 M
Slightly volatile
Property Plant Equipment4.7 M4.4 M2.2 M
Slightly volatile
Other Liabilities12.2 M15.4 M9.8 M
Slightly volatile
Other Assets956.3 K910.8 K464.8 K
Slightly volatile
Net Receivables37.6 M35.8 M12.7 M
Slightly volatile
Inventory7.1 M13.1 M5.7 M
Slightly volatile
Deferred Long Term Liabilities9.7 K10.2 K122.8 K
Slightly volatile
Non Current Liabilities Other10.2 M5.7 M7.1 M
Slightly volatile
Long Term Debt9.8 M12.5 M7 M
Slightly volatile
Short and Long Term Debt6 M9.8 M5.8 M
Pretty Stable
Net Invested Capital59.5 M46.9 M36.3 M
Slightly volatile
Preferred Stock Total Equity287323353
Slightly volatile
Capital Stock8559002.6 K
Very volatile
Long Term Debt Total8.9 M10.1 M11 M
Slightly volatile
Capital Lease Obligations2.5 M4.1 M2 M
Slightly volatile

Aytu BioScience Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization6.5 M6.2 M3.9 M
Slightly volatile
Selling General Administrative12.3 M20 M14.4 M
Slightly volatile
Other Operating Expenses43.1 M85.3 M51.3 M
Slightly volatile
Total Operating Expenses33 M61.7 M39 M
Slightly volatile
Total Revenue80.2 M76.3 M35.4 M
Slightly volatile
Gross Profit55.3 M52.7 M22.3 M
Slightly volatile
Research Development1.4 M1.5 M3.3 M
Very volatile
Interest Income388.8 K409.2 K979.4 K
Pretty Stable
Non Recurring167 K175.8 K2.9 M
Slightly volatile
Selling And Marketing Expenses25.9 M24 M14 M
Slightly volatile
Reconciled Depreciation6.6 M6.2 M5.5 M
Slightly volatile

Aytu BioScience Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow11.6 M23 M13.9 M
Slightly volatile
Depreciation3.3 M6.2 M3.9 M
Slightly volatile
End Period Cash Flow37.4 M35.6 M17.8 M
Slightly volatile
Stock Based Compensation629.3 K662.4 K1.6 M
Slightly volatile
Dividends Paid22 K24.7 K27 K
Slightly volatile
Issuance Of Capital Stock19.6 M13.4 M19.2 M
Very volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio289304106
Pretty Stable
PTB Ratio3.53.3362.0302
Slightly volatile
Days Sales Outstanding84.43154134
Slightly volatile
Book Value Per Share626.4 K596.6 K429.6 K
Slightly volatile
Average Payables5.4 K5.7 K758.1 K
Slightly volatile
Stock Based Compensation To Revenue16.518.48482.7088
Pretty Stable
Capex To Depreciation0.09060.09540.9741
Slightly volatile
PB Ratio3.53.3362.0302
Slightly volatile
Inventory Turnover1.611.622.0131
Very volatile
Days Of Inventory On Hand245234211
Pretty Stable
Sales General And Administrative To Revenue41.8139.820110.7094
Very volatile
Average Inventory4.5 K4.7 K1.4 M
Very volatile
Research And Ddevelopement To Revenue65.4468.88311.947
Slightly volatile
Capex To Revenue0.150.15780.3365
Slightly volatile
Cash Per Share308 K293.3 K215 K
Slightly volatile
Income Quality0.750.98620.7308
Pretty Stable
Intangibles To Total Assets0.650.68240.5422
Very volatile
Current Ratio0.970.5422.5978
Slightly volatile
Receivables Turnover2.332.453.8717
Very volatile
Shareholders Equity Per Share626.4 K596.6 K429.6 K
Slightly volatile
Debt To Equity0.90.85670.3046
Slightly volatile
Capex Per Share9811 K36.7 K
Slightly volatile
Average Receivables3.5 M3.3 M1.9 M
Slightly volatile
Revenue Per Share6.2 K6.5 K14.9 K
Slightly volatile
Interest Debt Per Share537.2 K511.6 K80.3 K
Slightly volatile
Debt To Assets0.360.38280.098
Slightly volatile
Operating Cycle361431349
Very volatile
Price Book Value Ratio3.53.3362.0302
Slightly volatile
Ebt Per Ebit1.081.00721.3886
Slightly volatile
Company Equity Multiplier1.622.23792.5478
Slightly volatile
Long Term Debt To Capitalization0.20.330.1168
Slightly volatile
Total Debt To Capitalization0.480.46140.1752
Slightly volatile
Debt Equity Ratio0.90.85670.3046
Slightly volatile
Quick Ratio0.870.54032.449
Slightly volatile
Net Income Per E B T0.920.87271.2223
Very volatile
Cash Ratio0.660.43332.039
Slightly volatile
Days Of Inventory Outstanding245234211
Pretty Stable
Days Of Sales Outstanding84.43154134
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.021.00171.2446
Pretty Stable
Price To Book Ratio3.53.3362.0302
Slightly volatile
Fixed Asset Turnover0.981.033816.496
Slightly volatile
Debt Ratio0.360.38280.098
Slightly volatile
Price Sales Ratio289304106
Pretty Stable
Asset Turnover0.00470.00490.2222
Slightly volatile
Gross Profit Margin30.028.57143.9966
Slightly volatile
Price Fair Value3.53.3362.0302
Slightly volatile

Aytu BioScience Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap23.8 M17.9 M25.2 M
Slightly volatile
Enterprise Value22.2 M19.9 M24.5 M
Slightly volatile

Aytu Fundamental Market Drivers

Forward Price Earnings3.6928
Cash And Short Term Investments31 M

Aytu Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Aytu BioScience Financial Statements

Aytu BioScience shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Aytu BioScience investors may analyze each financial statement separately, they are all interrelated. The changes in Aytu BioScience's assets and liabilities, for example, are also reflected in the revenues and expenses on on Aytu BioScience's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue44.4 M27.6 M
Total Revenue76.3 M80.2 M
Cost Of Revenue23.6 M15.4 M
Stock Based Compensation To Revenue 8.48  16.51 
Sales General And Administrative To Revenue 39.82  41.81 
Research And Ddevelopement To Revenue 68.88  65.44 
Capex To Revenue 0.16  0.15 
Revenue Per Share6.5 K6.2 K
Ebit Per Revenue(107.70)(102.32)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Aytu Stock Analysis

When running Aytu BioScience's price analysis, check to measure Aytu BioScience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aytu BioScience is operating at the current time. Most of Aytu BioScience's value examination focuses on studying past and present price action to predict the probability of Aytu BioScience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aytu BioScience's price. Additionally, you may evaluate how the addition of Aytu BioScience to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY